Ask AI

The Evolving and Transformative Role of Maintenance Therapy in the First-line Setting of HER2+ Metastatic Breast Cancer

Enhance your understanding of maintenance therapy for HER2+ MBC to individualize treatment plans and improve patient outcomes based on the latest clinical evidence and advancements through a certified on-demand webcast, expert-authored ClinicalThought commentary, certified case challenges, downloadable resources and slides, and a podcast.

Share

Program Content

Events

  • Live Event
    The Evolving and Transformative Role of Maintenance Therapy in the First-line Setting of HER2+ Metastatic Breast Cancer
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

ND HER2+ MCB Patient Checklist
Newly Diagnosed HER2+ Metastatic Breast Cancer: Patient–Provider Communication Checklist
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2025

ND HER2+ MBC Tx Options
Treatment Options and Considerations for Newly Diagnosed HER2+ Metastatic Breast Cancer: A Resource for Patients and Caregivers
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

Activities

Treating HR Pos HER2 Pos MBC
Interactive Case Challenge: Treatment of HR-Positive/HER2-Positive Metastatic Breast Cancer
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: February 03, 2026

Expires: August 02, 2026

Treating HER2 Positive BC With Brain Mets
Interactive Case Challenge: Treatment of HER2-Positive Breast Cancer With Brain Metastases
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2026

Expires: August 04, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.